ORCHARD THERAPEUTICS PLC Increase (Decrease) in Contract with Customer, Liability
ORCHARD THERAPEUTICS PLC reported Increase (Decrease) in Contract with Customer, Liability of -$286.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was -$93.00K.
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was -$86.00K.
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was -$107.00K.
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for the quarter ending 2022-12-31 was $4.15M.
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for fiscal 2022 was -$272.00K, a 102.07% decline from fiscal 2021.
- ORCHARD THERAPEUTICS PLC increase (decrease) in contract with customer, liability for fiscal 2021 was $13.12M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$179.00K derived: sum of 2 quarters · filed 2023-11-13 | -$286.00K 10-Q · filed 2023-11-13 | $3.86M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$193.00K 10-Q · filed 2023-08-10 | $3.96M derived: sum of 3 quarters · filed 2023-08-10 | -$327.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2023-03-31 | -$107.00K 10-Q · filed 2023-05-15 | $4.04M derived: sum of 2 quarters · filed 2023-05-15 | -$241.00K derived: sum of 3 quarters · filed 2023-11-13 | -$314.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$134.00K derived: sum of 2 quarters · filed 2023-11-13 | -$207.00K derived: sum of 3 quarters · filed 2023-11-13 | -$272.00K 10-K · filed 2023-03-14 | |
| 2022-09-30 | -$4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.36M derived: sum of 2 quarters · filed 2023-11-13 | -$4.42M 10-Q · filed 2023-11-13 | -$178.00K 10-Q · filed 2022-11-14 | -$5.02M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$138.00K 10-Q · filed 2023-08-10 | -$741.00K derived: sum of 3 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$65.00K 10-Q · filed 2023-05-15 | -$668.00K derived: sum of 2 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $13.12M 10-K · filed 2023-03-14 | |||
| 2021-09-30 | $13.72M 10-Q · filed 2022-11-14 |